Update on the Symptomatic Treatment of Huntington’s Disease: From Pathophysiology to Clinical Practice
International Journal of Molecular Sciences · 27.06.2025 · 26 (13) · 6220
DOI: 10.3390/ijms26136220 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.06.2025. Verfasst von Gonzalo Olmedo-Saura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medicine Department, Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, Spain. Hauptthemen laut MEDLINE: Huntington Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 252 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Huntington’s disease (HD) is the most common autosomal dominant neurodegenerative disorder, characterized by a triad of motor dysfunction, cognitive decline, and psychiatric disturbances. While recent efforts have focused on developing disease-modifying therapies, no treatment has yet demonstrated clinical efficacy. As a result, symptomatic treatment remains the cornerstone of care. However, high-quality evidence from large randomized trials is limited, and therapeutic decisions must rely on clinical expertise and extrapolation from other neurological or psychiatric conditions. This narrative review provides a comprehensive and practical overview of symptomatic treatment strategies for HD with emphasis on the pathophysiological underpinnings of each symptom and the molecular mechanisms of available and emerging therapies, aiming to support rational, individualized management. Finally, we highlight the critical role of non-pharmacological interventions and the need for multidisciplinary approaches to optimize patient outcomes and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medicine Department, Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, Spain.
- Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
- Institut d'Investigacions Biomèdiques-Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.
- Centro de Investigación Biomédica en Red-Enfermedades Neurodegenerativas (CIBERNED), 28029 Madrid, Spain.
- European Huntington's Disease Network (EHDN), 89081 Ulm, Germany.
ORCID-Profile: Gonzalo Olmedo-Saura, Eugenio Bernardi, Saül Martínez-Horta, Javier Pagonabarraga, Jaime Kulisevsky
Zitieren
APA
Olmedo-Saura, G., Bernardi, E., Bojtos, L., Martínez-Horta, S., Pagonabarraga, J., Kulisevsky, J., & Pérez-Pérez, J. (2025). Update on the Symptomatic Treatment of Huntington’s Disease: From Pathophysiology to Clinical Practice. International Journal of Molecular Sciences, 26(13), 6220. https://doi.org/10.3390/ijms26136220
Vancouver
Olmedo-Saura G, Bernardi E, Bojtos L, Martínez-Horta S, Pagonabarraga J, Kulisevsky J, et al. Update on the Symptomatic Treatment of Huntington’s Disease: From Pathophysiology to Clinical Practice. International Journal of Molecular Sciences. 2025;26(13):6220. doi:10.3390/ijms26136220
BibTeX
@article{OlmedoSaura2025,
author = {Olmedo-Saura, Gonzalo and Bernardi, Eugenio and Bojtos, Lidia and Martínez-Horta, Saül and Pagonabarraga, Javier and Kulisevsky, Jaime and Pérez-Pérez, Jesús},
title = {Update on the Symptomatic Treatment of Huntington’s Disease: From Pathophysiology to Clinical Practice},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {13},
pages = {6220},
doi = {10.3390/ijms26136220}
}
EUVIMED